The Secret Life of Disco Biscuits
The Utilization of MDMA for the treatment of PTSD
The drug called 3,4-Methylenedioxymethamphetamine, commonly known as MDMA, or Ecstasy is proving to be useful for treating clients who present with post-traumatic stress disorder. The drug’s current scheduling classification limits how the drug can be used in clinical trials. Recent research shows positive trends for individuals who simultaneously undergo MDMA treatment and psychotherapy. Some cautions and limitations have been noted. Reclassification of the drug would help increase future research opportunities.
Keywords: PTSD, MDMA, treatment, drug classification, clinical trials
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).